Skip to main content
Top
Published in: Trials 1/2011

Open Access 01-12-2011 | Methodology

The methodology for developing a prospective meta-analysis in the family planning community

Authors: David K Turok, Eve Espey, Alison B Edelman, Pamela S Lotke, Eva H Lathrop, Stephanie B Teal, Janet C Jacobson, Sara E Simonsen, Kenneth F Schulz

Published in: Trials | Issue 1/2011

Login to get access

Abstract

Background

Prospective meta-analysis (PMA) is a collaborative research design in which individual sites perform randomized controlled trials (RCTs) and pool the data for meta-analysis. Members of the PMA collaboration agree upon specific research interventions and outcome measures, ideally before initiation but at least prior to any individual trial publishing results. This allows for uniform reporting of primary and secondary outcomes. With this approach, heterogeneity among trials contributing data for the final meta-analysis is minimized while each site maintains the freedom to design a specific trial. This paper describes the process of creating a PMA collaboration to evaluate the impact of misoprostol on ease of intrauterine device (IUD) insertion in nulliparous women.

Methods

After the principal investigator developed a preliminary PMA protocol, he identified potential collaborating investigators at other sites. One site already had a trial underway and another site was in the planning stages of a trial meeting PMA requirements. Investigators at six sites joined the PMA collaborative. Each site committed to enroll subjects to meet a pre-determined total sample size. A final common research plan and site responsibilities were developed and agreed upon through email and face-to-face meetings. Each site committed to contribute individual patient data to the PMA collaboration, and these data will be analyzed and prepared as a multi-site publication. Individual sites retain the ability to analyze and publish their site's independent findings.

Results

All six sites have obtained Institutional Review Board approval and each has obtained individual funding to meet the needs of that site's study. Sites have shared resources including study protocols and consents to decrease costs and improve study flow. This PMA protocol is registered with the Cochrane Collaboration and data will be analyzed according to Cochrane standards for meta-analysis.

Conclusions

PMA is a novel research method that improves meta-analysis by including several study sites, establishing uniform reporting of specific outcomes, and yet allowing some independence on the part of individual sites with respect to the conduct of research. The inclusion of several sites increases statistical power to address important clinical questions. Compared to multi-center trials, PMA methodology encourages collaboration, aids in the development of new investigators, decreases study costs, and decreases time to publication.

Trial Registration

Literature
1.
go back to reference Jones AP: Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials. 2009, 6 (1): 16-27. 10.1177/1740774508100984.CrossRefPubMed Jones AP: Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials. 2009, 6 (1): 16-27. 10.1177/1740774508100984.CrossRefPubMed
2.
go back to reference Reade MC: Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med. 2010, 36 (1): 11-21. 10.1007/s00134-009-1650-x.CrossRefPubMed Reade MC: Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med. 2010, 36 (1): 11-21. 10.1007/s00134-009-1650-x.CrossRefPubMed
4.
go back to reference Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. Am J Cardiol. 1995, 75 (16): 1130-4. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. Am J Cardiol. 1995, 75 (16): 1130-4.
5.
go back to reference Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens. 1998, 16 (2): 127-37. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens. 1998, 16 (2): 127-37.
6.
go back to reference Margitic SE: Hospital Outcomes Project for the Elderly (HOPE): rationale and design for a prospective pooled analysis. J Am Geriatr Soc. 1993, 41 (3): 258-67.CrossRefPubMed Margitic SE: Hospital Outcomes Project for the Elderly (HOPE): rationale and design for a prospective pooled analysis. J Am Geriatr Soc. 1993, 41 (3): 258-67.CrossRefPubMed
7.
go back to reference Margitic SE: Lessons learned from a prospective meta-analysis. J Am Geriatr Soc. 1995, 43 (4): 435-9.CrossRefPubMed Margitic SE: Lessons learned from a prospective meta-analysis. J Am Geriatr Soc. 1995, 43 (4): 435-9.CrossRefPubMed
8.
go back to reference Schunkert H: Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008, 117 (13): 1675-84. 10.1161/CIRCULATIONAHA.107.730614.CrossRefPubMedPubMedCentral Schunkert H: Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008, 117 (13): 1675-84. 10.1161/CIRCULATIONAHA.107.730614.CrossRefPubMedPubMedCentral
9.
go back to reference Sims AM: Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008, 67 (9): 1305-9.CrossRefPubMed Sims AM: Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008, 67 (9): 1305-9.CrossRefPubMed
10.
go back to reference Writer WD: Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998, 81 (5): 713-7.CrossRefPubMed Writer WD: Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998, 81 (5): 713-7.CrossRefPubMed
11.
go back to reference Valsecchi MG, Masera G: A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. Ann Oncol. 1996, 7 (10): 1005-8.CrossRefPubMed Valsecchi MG, Masera G: A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. Ann Oncol. 1996, 7 (10): 1005-8.CrossRefPubMed
12.
13.
go back to reference Baigent C: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366 (9493): 1267-78.CrossRefPubMed Baigent C: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366 (9493): 1267-78.CrossRefPubMed
15.
go back to reference Meckstroth KR: Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstetrics and gynecology. 2006, 108 (3 Pt 1): 582-90.CrossRefPubMed Meckstroth KR: Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstetrics and gynecology. 2006, 108 (3 Pt 1): 582-90.CrossRefPubMed
16.
go back to reference Tang OS: Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction. 2002, 17 (2): 332-6. 10.1093/humrep/17.2.332.CrossRefPubMed Tang OS: Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction. 2002, 17 (2): 332-6. 10.1093/humrep/17.2.332.CrossRefPubMed
17.
go back to reference Use of the Mirena™ LNG-IUS and Paragard™ CuT380A intrauterine devices in nulliparous women: Release date 15 December 2009 SFP Guideline 20092. Contraception. 2010, 81 (5): 367-371. Use of the Mirena™ LNG-IUS and Paragard™ CuT380A intrauterine devices in nulliparous women: Release date 15 December 2009 SFP Guideline 20092. Contraception. 2010, 81 (5): 367-371.
18.
go back to reference ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol. 2007, 110 (6): 1493-5. 10.1097/01.AOG.0000291575.93944.1a. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol. 2007, 110 (6): 1493-5. 10.1097/01.AOG.0000291575.93944.1a.
19.
go back to reference ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 59, January 2005. Intrauterine device. Obstet Gynecol. 2005, 105 (1): 223-32. 10.1097/00006250-200501000-00060. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 59, January 2005. Intrauterine device. Obstet Gynecol. 2005, 105 (1): 223-32. 10.1097/00006250-200501000-00060.
22.
go back to reference Allen RH: Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2009, 3: CD007373-PubMed Allen RH: Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2009, 3: CD007373-PubMed
23.
go back to reference Allen RH, Goldberg AB: Cervical dilation before first-trimester surgical abortion (< 14 weeks' gestation). SFP Guideline 20071. Contraception. 2007, 76 (2): 139-56.CrossRefPubMed Allen RH, Goldberg AB: Cervical dilation before first-trimester surgical abortion (< 14 weeks' gestation). SFP Guideline 20071. Contraception. 2007, 76 (2): 139-56.CrossRefPubMed
24.
go back to reference Hayes JL, Fox MC: Cervical dilation in second-trimester abortion. Clin Obstet Gynecol. 2009, 52 (2): 171-8. 10.1097/GRF.0b013e3181a2b3cd.CrossRefPubMed Hayes JL, Fox MC: Cervical dilation in second-trimester abortion. Clin Obstet Gynecol. 2009, 52 (2): 171-8. 10.1097/GRF.0b013e3181a2b3cd.CrossRefPubMed
25.
go back to reference Batukan C: Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril. 2008, 89 (4): 966-73. 10.1016/j.fertnstert.2007.03.099.CrossRefPubMed Batukan C: Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril. 2008, 89 (4): 966-73. 10.1016/j.fertnstert.2007.03.099.CrossRefPubMed
26.
go back to reference Oppegaard KS: Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design. BJOG. 2008, 115 (5): 663-10.1111/j.1471-0528.2007.01628.x. e1-9CrossRefPubMedPubMedCentral Oppegaard KS: Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design. BJOG. 2008, 115 (5): 663-10.1111/j.1471-0528.2007.01628.x. e1-9CrossRefPubMedPubMedCentral
27.
go back to reference Ngai SW: Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod. 1997, 12 (11): 2373-5. 10.1093/humrep/12.11.2373.CrossRefPubMed Ngai SW: Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod. 1997, 12 (11): 2373-5. 10.1093/humrep/12.11.2373.CrossRefPubMed
28.
go back to reference Saav I: Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007, 22 (10): 2647-52. 10.1093/humrep/dem244.CrossRefPubMed Saav I: Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007, 22 (10): 2647-52. 10.1093/humrep/dem244.CrossRefPubMed
29.
go back to reference Oskari H: Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2010, 81 (6): 481-486. 10.1016/j.contraception.2010.01.020.CrossRef Oskari H: Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2010, 81 (6): 481-486. 10.1016/j.contraception.2010.01.020.CrossRef
30.
go back to reference Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010, 11: 32-10.1186/1745-6215-11-32.CrossRefPubMedPubMedCentral Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010, 11: 32-10.1186/1745-6215-11-32.CrossRefPubMedPubMedCentral
31.
go back to reference Higgins J, Green S, Cochrane Collaboration: Cochrane handbook for systematic reviews of interventions. Cochrane book series. 2008, Chichester, West Sussex; Hoboken NJ: John Wiley & Sons Higgins J, Green S, Cochrane Collaboration: Cochrane handbook for systematic reviews of interventions. Cochrane book series. 2008, Chichester, West Sussex; Hoboken NJ: John Wiley & Sons
Metadata
Title
The methodology for developing a prospective meta-analysis in the family planning community
Authors
David K Turok
Eve Espey
Alison B Edelman
Pamela S Lotke
Eva H Lathrop
Stephanie B Teal
Janet C Jacobson
Sara E Simonsen
Kenneth F Schulz
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-104

Other articles of this Issue 1/2011

Trials 1/2011 Go to the issue